Amgen's Leukemia Rx is Effective & Expensive
Immune Diseases Were More Common in Those Born by C-Section
FDA Expands Approval of Rx for Rare Blood and Bone Disease
FDA Approves New Cancer Medication
Chronic Myelogenous Leukemia
About 20,000 people in the United States are affected by chronic myelogenous leukemia, and about 4,500 people are newly diagnosed every year.
Chronic myelogenous leukemia, also known as CML, is a slowly progressing blood and bone marrow disease that usually develops during or after middle age and rarely affects children.
Normally, the bone marrow produces blood stem cells that develop into mature blood cells over time. A blood stem cell may become a myeloid stem cell which develops into either red blood cells, platelets or...